The team at DropGenie uses digital microfluidics to perform gene editing screens on small numbers of patient cells, accelerating the discovery of new drugs.
By watching brain organoids develop, researchers observed surprising abnormalities caused by mutations in a gene related to early-onset Alzheimer’s disease.
Researchers use fluorescence-based imaging to visualize a cellular invasion event in worms, revealing candidates for gene knockdown strategies to block metastasis.